PAXLOVID Drug Patent Profile
✉ Email this page to a colleague
When do Paxlovid patents expire, and when can generic versions of Paxlovid launch?
Paxlovid is a drug marketed by Pfizer and is included in one NDA. There are two patents protecting this drug.
The generic ingredient in PAXLOVID is nirmatrelvir; ritonavir. One supplier is listed for this compound. Additional details are available on the nirmatrelvir; ritonavir profile page.
DrugPatentWatch® Generic Entry Outlook for Paxlovid
Indicators of Generic Entry
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PAXLOVID?
- What are the global sales for PAXLOVID?
- What is Average Wholesale Price for PAXLOVID?
Summary for PAXLOVID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for PAXLOVID |
| What excipients (inactive ingredients) are in PAXLOVID? | PAXLOVID excipients list |
| DailyMed Link: | PAXLOVID at DailyMed |
US Patents and Regulatory Information for PAXLOVID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | PAXLOVID (COPACKAGED) | nirmatrelvir; ritonavir | TABLET;ORAL | 217188-001 | May 25, 2023 | RX | Yes | Yes | 11,541,034 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pfizer | PAXLOVID (COPACKAGED) | nirmatrelvir; ritonavir | TABLET;ORAL | 217188-001 | May 25, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pfizer | PAXLOVID (COPACKAGED) | nirmatrelvir; ritonavir | TABLET;ORAL | 217188-001 | May 25, 2023 | RX | Yes | Yes | 11,351,149 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Pfizer | PAXLOVID (COPACKAGED) | nirmatrelvir; ritonavir | TABLET;ORAL | 217188-001 | May 25, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
